Tracer library / [18F]FET-bAG-TOCA
[18F]FET-bAG-TOCA
Also written as [18F]FET-bAG-TOCA; [F-18]FET-bAG-TOCA; FET-bAG-TOCA; fluoroethyl triazole [Tyr3]octreotate
- Radionuclide
- F-18 t½ 109.7 min
- Modality
- PET
- Production route
- Cyclotron liquid target
- Stage
- Research
- Syntheses indexed
- 0
What it is
- Compound class
- Peptide (somatostatin analogue)
- Target / mechanism
- SSTR2 PMID 32252406 / DOI 10.1021/acs.jmedchem.9b02017
- Clinical application
- Neuroendocrine tumours PMID 27173162; PMID 38331457 / DOI 10.2967/jnumed.123.266383
- Theranostic pair
- [177Lu]Lu-DOTATATE
Regulatory status
- FDA
- No Drugs@FDA / openFDA drug registry — no approved application found; search: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=FET-bAG-TOCA
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Published syntheses
No synthesis has been parsed for this agent yet.
Precursor
- Common precursor
- —
- Suppliers seen in the literature
- —
- Typical final purification
- HPLC
Need this precursor?We can point you to suppliers for [18F]FET-bAG-TOCA, or handle the enquiry for you.
Get in touchQuality control Preliminary - inferred from compound class
- Ph. Eur. monograph
- not verified No Ph. Eur. check is recorded for this entry.
- USP monograph
- not verified No USP check is recorded for this entry.
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); receptor ligand with a saturable target -> molar activity (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [18F]FET-bAG-TOCA.
Get in touch